{"retracted":false,"update":{"timestamp":1410393600000,"doi":"10.1007/s12325-014-0150-8","type":"correction"},"doi":"10.1007/s12325-013-0060-1","journal":"Advances in Therapy","publisher":"Springer Nature","title":"Erratum to: Everolimus Plus Exemestane in Postmenopausal Patients with HR+ Breast Cancer: BOLERO-2 Final Progression-Free Survival Analysis"}
